IGFBP3 and major depressive disorder: IGF-1 and IGFBP-3 serum levels were significantly decreased in MDD responders after 35 days, but not 14 days, of amitriptyline monotherapy, whereas only IGF-1 was significantly reduced in a paroxetine-treated group.